newsfilter
← Latest News
Earnings Call Transcripts·

MBRX_Venetoclax Patients - JTC TEAM

We always have to be careful when discussing pooled data because there are minor differences in the protocol between the trials. But when you combine this interim phase three data with the phase two data we already had,